Abstract:OBJECTIVE:To construct a recombinant lentivirus vector containing fusion gene NT4-p53(N15)-Ant and transfer it into HepG2 cancer cells for gene therapy.METHODS:The gene of p53(N15)-Ant was obtained by T-vector method. After restriction enzyme digestion, the interest gene of p53(N15)-Ant was inserted in pBV220/NT4 vector and fusion gene of NT4-p53(N15)-Ant was subcloned into the plasmid of lentivirus and cotransferred into HEK-293 cells with helper plasmid. The recombinant lentivirus was produced by homologous recombination of the above mentioned two plasmids in HEK-293 cells and its titer was measured by plaque-forming. The expression of LV. NT4-p53-Ant in transfected HepG2 cells was finally confirmed by reverse transcription polymerase chain reaction (RT-PCR) procedure. The effect of LV. NT4-p53(N15)-Ant on HepG2 cells was measured by a colorimetric 3-[4,5-dimethyl thiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. The inhibition effect on HepG2 cells of LV. NT4-p53(N15)-Ant and its potential mechanism was detected by light microscopy, electron microscopy, MTT, LDH-release assay and annexin V-PI double staining.RESULTS:The gene of p53(N15)-Ant was confirmed by restriction enzyme digestion and DNA sequencing. High titer of the recombinant lentivirus was obtained by homologous recombination in HEK-293 cell lines (1 x 10(11) pfu/ml), and the expression of NT4-p53(N15)-Ant gene in HepG2 cells was confirmed by RT-PCR. The viability of HepG2 cells was decreased to 83.4%, 46.9% and 33.9%, at 24 h, 48 h and 72 h, respectively, after infection by LV. NT4-p53(N15)-Ant. Compared with the LV. EGFP control group, there were significant differences (P < 0.01). The LDH level in HepG2 cells infected by LV. NT4-p53(N15)-Ant at 48 h, 72 h and 96 h after infection was 682 IU/L, 815 IU/L and 979 IU/L, respectively, significantly increased than that in the LV. EGFP group (P < 0.01), indicating the cell membrane destruction.CONCLUSION:The recombinant lentivirus vector encoding gene NT4-p53(N15)-Ant is successfully constructed in this experiment by molecular cloning and recombination in vitro techniques, and the results suggested that this fusion gene has an anti-tumor effect, which provides the basis for further research on recombinant adenovirus for cancer gene therapy.

Construction of a New Type Replication-Selective Adenovirus CNHK600-p53 and Its Inhibitory Effect on Hepatocellular Carcinoma Cells in Vitro

CONSTRUCTION OF A NOVEL GENE-VIRAL THERAPEUTIC SYSTEM CNHK500-p53 AGAINST LIVER CANCER

Effect of Replicating Adenovirus Harboring P53 Gene on Chemosensitivity of Hepatocarcinoma Cell Line

The Construction of a Hepatoma-Specific Adeno-Associated Virus Vectorcarrying P53 Gene

RESEARCH ON REVERSAL EFFECTS OF REPLICATION-selective adenovirus CNHK600-p53 ON DRUG-RESISTANT HEPATOMA CELL LINE SMMC7721

Effects of rAd-p53 on growth of human hepatic carcinoma cells

[Tumor-Targeting Expression of a New Tumor Suppressor Gene HCCS1 and Its Tumor-Selective Inhibitory Effects on Hepatocellular Carcinoma].

Recombinant Lentivirus-Mediated Gene Transfer of NT4-p53 (N15 ) -Ant Inhibits the Growth of Hepatocellular Carcinoma Cells in Vitro

A Novel Replication-competent Adenovirus CNHK500 in the Treatment of Heptocellular Carcinoma In Vitro

Construction and Identification of Recombinant Adenovirus Vector Harboring Fusion Gene NT4-p53 (N15)-Ant

Construction of adenovirus vector expressing TIP30 and its tumor suppressive effect in vitro and in vivo

Construction of Recombinant Adenovirus Harboring Fusion Gene NT4p53(C22)Ant and Its Killing Effect on HepG2 Tumor Cells

A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers.

Experimental study of the effects of rAd-p53 on the radiosensitivity of human hepatocellular carcionoma

Adenovirus-Mediated Tbid Overexpression Results In Therapeutic Effects On P53-Resistant Hepatocellular Carcinoma

[Construction and Antitumor Effect of Recombinant Adenovirus Vector Containing Heterofusion Gene NT4p53(N15)Ant].

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma

The in Vitro and in Vivo Effect of Adeno-Associated Virus-Mediated Combined P53,p16 and P21 Gene Transfection on Human Hepatic Carcinoma Cell Lines

Increased Safety With Preserved Antitumoral Efficacy On Hepatocellular Carcinoma With Dual-Regulated Oncolytic Adenovirus

Construction of Conditionally Replication-Competent Adenoviral Vectors Targeting Hepatocarcinoma and Their in Vitro Anti-Tumor Effect